Rocket Pharmaceuticals Cash Flow Statement (2014-2026) | RCKT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-380.53M-252.62M-43.95M-126.90M-126.26M-145.59M-68.30M-157.55M-188.38M-190.82M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-118.51M-98.92M-43.75M-48.82M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
7.31M6.99M7.04M6.27M7.37M7.68M9.69M8.91M10.24M10.32M9.93M10.25M11.33M11.25M11.09M10.33M10.86M9.76M6.11M8.49M
Gains from Investment Securities (Quarter)
1.11M-2.88M-0.10M-0.00M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-38.53M-27.41M-30.94M-39.22M-39.04M-43.86M-56.02M-57.56M-50.87M-57.15M-29.34M-56.86M-53.82M-52.10M-46.94M-55.79M-48.96M-50.42M-34.84M-45.39M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.73M-0.74M-0.80M-0.58M-0.40M-0.16M1.08M2.42M2.68M2.28M3.27M2.76M2.24M1.85M1.22M2.19M2.22M1.68M1.21M1.23M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.70M0.80M1.05M0.80M1.00M1.14M1.19M1.22M1.40M1.72M1.83M1.85M1.82M2.45M2.04M2.70M1.68M1.61M
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
-0.01M-2.81M2.79M-0.01M2.56M4.64M2.48M-7.75M7.23M-0.20M10.87M-2.14M2.22M5.21M-5.21M2.86M-12.25M9.30M0.00M
Other Working Capital Changes (Quarter)
-0.03M-0.03M-0.03M0.10M0.01M0.02M
Investing Activities
Capital Expenditures (Quarter)
1.45M3.88M1.97M1.96M2.90M0.50M-3.26M1.79M-0.53M0.41M14.77M2.04M1.93M-3.70M5.60M0.05M-0.05M0.36M0.08M0.09M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
105.61M53.56M38.30M81.98M81.69M58.41M50.82M62.34M108.25M66.40M72.34M101.02M96.13M99.83M86.48M82.26M84.50M123.00M91.00M66.25M
Cash from Investing Activities (Quarter)
49.35M-18.19M16.86M-62.99M78.79M23.46M-108.58M-36.72M31.21M48.25M-140.81M35.03M55.62M78.92M-37.87M-58.03M31.76M93.62M36.42M17.45M
Financing Activities
Other financing activities (Quarter)
1.11M0.28M-10.19M0.63M1.11M-1.11M2.22M1.18M1.53M0.18M0.32M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
11.04M8.47M11.14M9.14M9.47M12.73M13.14M14.65M14.88M11.43M14.86M12.35M12.74M16.15M16.04M13.87M13.43M13.78M12.16M10.02M
Net Equity Issued and Repurchased (Quarter)
-8.79M17.24M29.30M61.60M17.22M171.66M-171.66M63.80M118.73M
Misc.
Cash from Financing Activities (Quarter)
1.11M26.64M1.14M0.08M17.25M29.53M108.44M18.34M0.18M189.49M0.39M1.18M1.53M0.18M182.85M0.21M-0.07M-0.00M
Change in Cash (Quarter)
11.94M-18.96M-12.94M-102.14M57.00M9.13M-56.17M-75.94M-19.48M180.59M-169.75M-20.64M3.33M26.99M98.04M-113.83M-16.99M43.13M1.58M-27.95M
Free Cash Flow (Quarter)
-39.97M-31.29M-32.91M-41.18M-41.94M-44.36M-52.76M-59.35M-50.34M-57.55M-44.10M-58.89M-55.75M-48.40M-52.54M-55.84M-48.91M-50.78M-34.92M-45.49M
Net Cash Flow (Quarter)
11.94M-18.96M-12.94M-102.14M57.00M9.13M-56.17M-75.94M-19.48M180.59M-169.75M-20.64M3.33M26.99M98.04M-113.83M-16.99M43.13M1.58M-27.95M